👉Integrated home #dialysis model facilitates #transition from #peritoneal dialysis to self-care #hemodialysis: evidence from our 🇧🇪 cohort at Clin univ St-Luc 🔗 DOI:10.1093/joneph/aajag004 Key message: A “PD first → self-care HD second” pathway is feasible and helps preserve patient autonomy.

Busy schedule? SCM26 fits your timeline. Register for SCM On-Demand to watch recordings of most sessions, available 48 hours after they occur. Learn on your schedule: www.kidney.org/spring-clini... #NKFClinicals #MedEd #Nephrology #NephSky

💡Join us for the RPA/ISGD Clinical Trials Bootcamp - designed for community nephrologists to establish robust research programs. Register here: bit.ly/RPA-ISGD-CTB Including: ✔️ Building the Business Plan & ROI ✔️ Executing the Plan ✔️ Support & Logistics ✔️ Strategies for varied practice settings

Commentary The expanding role of complement inhibitors in the treatment of IgA nephropathy doi.org/10.1016/j.kint.2025.12.015 Original article: doi.org/10.1016/j.kint.2025.11.017 #MedSky #NephSky #IgAN @ucm.es

Can comprehensive genetic testing effectively identify the underlying genetic causes of pediatric kidney cysts and improve diagnostic accuracy and clinical management, particularly in children with or without a known family history of kidney disease? Read #ASNCJASN kidney.pub/CJASN1027

The newest journal Kidney International Case Reports KICR launched by the international Society of Nephrology has just put out its inaugural group of articles (in press) & an editorial. Do read them at this link 👉 www.sciencedirect.com/journal/kidn... @theisn.org @christosargyrop.bsky.social

JASN encourages investigators to submit their late-breaking clinical trial (LBCT) manuscripts​ for rapid consideration and peer review and, if accepted, online publication concurrent with #ERA26. More info: https://bit.ly/JASNLBCT

Integration of connected dialysis machines, remote patient monitoring, and AI-driven analytics (digital dialysis) offers a path to more robust, personalized, and green online hemodiafiltration (HDF) delivery. Read more in #ASNKidneyNews kidney.pub/KN1803-14#ASNKidneyNews

Markers of #Mineral #Metabolism in Children with CKD Stages 2-5D #VisualAbstract by Brian Rifkin https://www.kireports.org/article/S2468-0249(26)00031-8/fulltext

📑 Comments are invited on a draft clinical practice guideline on the long-term management of kidney transplant recipients, covering follow-up, immunosuppression, rejection, cardiovascular risk, infection, bone health, malignancy & reproductive issues. Find out more: https://ow.ly/5nK150Yka2y

The Pathophysiological Mechanism of #Beni-koji #Choleste-Help or #Puberulic Acid–Induced Kidney Injury #AKI #VisualAbstract by @krishnadoctor1 https://www.kireports.org/article/S2468-0249(26)00024-0/fulltext

Special Collection: World Kidney Day Accelerometry-Derived Physical Activity Levels and Mortality in Hemodialysis Patients: A Prospective Cohort Study bit.ly/4j9tE3e

Dialysis is a miracle—but have we begun to take it for granted? This episode challenges us to rethink how dialysis has shaped nephrology’s priorities, innovation, and identity. 🎧 bit.ly/3DamjQ9 #KidneyCommute #Dialysis #Medical #Nephrology

Simultaneous initiation of finerenone and empagliflozin was effective and well tolerated among CONFIDENCE study participants from Asia, consistent with the overall population ca. 2026 from @asnpublications.bsky.social #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/40965042/

Classic Fred Luft #Nephrology 101 editorial on a study testing the effect of potassium supplement on natriuresis: Eliminating sodium with potassium 🔗 academic.oup.com/ndt/article/... #NephSky #MedSky 🧪

Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizon doi.org/10.1093/ckj/...

Risk-based referral model to nephrologist specialist care in Stockholm doi.org/10.1093/ndt/...

#NephGR tomorrow! @sbrimble.bsky.social on TMA in cancer and the St Joe’s Hamilton onconephrology program #NephSky

In a #ASNCJASN Kidney Cross-Talk, authors explore recent evidence on Lipoprotein(a) and chronic kidney disease (CKD). Read more: kidney.pub/CJASN0968 Bob Roshanravan

CKD for the Primary Care Provider ca. 2026 #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/41152063/

🔬 New Data Deserves a Platform! The Late-Breaking Abstract Call for SCM26 is open. 📌 Must include results from major clinical trials or epidemiological studies to be considered for review. Learn More: bit.ly/47TaBq4 #Nephrology #MedEd #NKFClinicals #NephSky

Environmental Impacts of Kidney Replacement Therapies: A Comparative Lifecycle Assessment bit.ly/3KNKibh #OpenAccess

The January issue of Kidney News is now online! Topics this month include: ⦁ A special section on Kidney Watch 2026, top areas to watch this year in nephrology ⦁ The ASN President's Update and new strategic plan Explore the issue: kidney.pub/KN1801-01 #ASNKidneyNews Kenar Jhaveri, MD#ASNKidneyNews

The Italian Society of Nephrology expresses its deep sorrow for the passing of Prof. Claudio Ponticelli, a pioneer in nephrology and an outstanding scientist and mentor. Our heartfelt condolences to his family and colleagues. #RIP #Nephrology

Erectile dysfunction is prevalent among patients with CKD. Read about the mechanisms and treatments at this intersection in #ASNKidneyNews kidney.pub/KN1712-14#ASNKidneyNews

Quantifying APOL1, Human Leukocyte Antigen, and Other Genetic Contributions to Unexplained Kidney Failure #OpenAccess bit.ly/4nfGoXe

#CKDs at the Crossroads: From Failures to #Future #Therapies https://doi.org/10.1016/j.ekir.2025.09.050#CKDs#Future#Therapies#KIRReview

📣Calling all #ResidentDoctors & #MedicalStudents! Thinking about a career in #Nephrology? join our taster event! Hear from renal registrars & consultants, learn about key conditions, explore career pathways & get tips for CVs & interviews. 👉https://ow.ly/YXRr50XyH0y#ResidentDoctors#MedicalStudents#Nephrology?#RenalMedicine #KidneyCare

NEW on #AJKDBlog: AJKDBlog’s Interviews Editor, Timothy Yau chatted with Kristen L. Nowak and Michel Chonchol about the complicated interplay between CKD and systemic inflammation, and new targets/pathways that could improve kidney and cardiovascular outcomes. bit.ly/4o63tv6 (FREE)

𝗜𝗡𝗦𝗜𝗚𝗛𝗧 is out! 🌍 ✨WCN’26 joint sessions ✨ New onconephrology case ✨ ISN Journal summaries on APOL1 kidney disease and expanding peritoneal dialysis in India ✨ New language of Kidney Health Quiz (Swahili) and ISN SGLT2i Toolkit (German and Spanish) and more! ➡️http://lite.spr.ly/6...

#UrinarySediment from a pt with #AKI #RPGN due to suspected MPO-AAV-GN inspected with Sternheimer stain: WBC cast (bright field), broad RBC cast (bright), waxy cast (bright), and granular cast w/Ca Oxalate monohydrate crystals (oblique). #OchsnerNephrology #UrineMicroscopy

Explores practical strategies for nutrition care in older adults with CKD. Learn how to integrate medical nutrition therapy with geriatric care using the 5 M’s framework and support individualized approaches for complex patients. 📚

Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction doi.org/10.1093/ndt/...

⚠ @kireports.bsky.social November issue is out! Read the latest news in research, highlights from current literature, comprehensive reviews, and in-depth case studies. www.kireports.org/cu... #ThisIsISN #Nephrology #Journal #Research #KidneyCommunity #Kidney #OpenAccess

The November 2025 issue is available now! Check out the plain-language summaries on what inspired each study, the basic approach taken, what was learned, and why it matters: bit.ly/3X1XpZj

The recording of our joint webinar with @theisn.org: "What's New in Patient Training", focused on the recently published Position Paper on Teaching #PeritonealDialysis to Patients and Caregivers, is already available on our Youtube channel: buff.ly/P2N0NGV

The opening plenary at #KidneyWk looks phenomenal Renal RCT Renaissance is upon us (LBCT list drops tomorrow) www.asn-online.org/education/ki...

Core Curriculum by Craig E. Gordon et al: Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025 bit.ly/465twwK (FREE)

Excellent thread below I will also plug this talk by Paola Romagnani on podocytopathies youtu.be/bRMeqaGgA9I?... #GlomCon #NephGR

𝗧𝗢𝗗𝗔𝗬: ISN Webinar: "Optimizing RAASi Therapy in Clinical Practice: A Case-Based Discussion." 🗓️ September 17 🕓 4 pm CEST 🔗 Free registration: http://lite.spr.ly/6... This webinar is supported by @astra-zeneca.bsky.social and CSL Vifor

📣 Registration for #ISNWCN 2026 is open. This is your chance to be part of the leading global congress on kidney care! ✔️ Register early with exclusive discounted rates ✔️Apply for a travel grant We can’t wait to welcome you in Yokohama! Secure your spot today ➡️http://lite.spr.ly/6...

Horisberger et al separate Lupus nephritis patients in 3 groups by blood: healthy-like, interferon-dominant and CD8 T cell-dominant. The CD8 T cell-dominant group had the highest biopsy activity score and highest response rate after 1 year; the healthy-like the most chronic damage. 🧪 ⑂ #NephSky 1/

Weekend Briefing for September 6, 2025: New Images in Clinical Medicine: Acute Epididymo-orchitis in IgA Vasculitis nej.md/4m4UJV0 Five New Perspectives: 1️⃣ Caring for Patients with IDDs nej.md/47YdUfB

How common is kidney failure with MCD and FSGS? More than we think … @brianrifkin.bsky.social breaks down the recent @asnpublications.bsky.social JASN paper from the RaDaR study www.nephjc.com/news/nephjc-...

New in #ASNJASN and at #Hypertension25: In a randomized, double-blind, placebo-controlled trial, Baxdrostat reduced systolic blood pressure in patients with CKD and uncontrolled hypertension. Read more about its safety and efficacy in patients with CKD here: kidney.pub/JASN0849

Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled #Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial ca. 2025 from @asnpublications.bsky.social @escardio.bsky.social #Nephpearls #NephSky #ESCCongress 👉 journals.lww.com/jasn/fulltex...